ENZOLYTICS (ENZC) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 111 252 sessions, September 22, 2025 to September 22, 2026
- Largest daily move
- +100% close of December 26, 2025
- 1-year change
- +50% closing prices, September 22, 2025 to September 22, 2026
- 5-year change
- -99.8% closing prices, September 22, 2021 to September 22, 2026
Company Description
ENZOLYTICS (OTC: ENZC) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.4M.
ENZC has gained 50.0% over the past year. The last closing price was $0.0003.
This page collects what Stock Titan holds for ENZC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ENZOLYTICS (ENZC) closed at $0.0003 on September 22, 2026. Over the past 12 months, the price has gained 50.0%.
ENZC Metrics & Rankings
Price returns through September 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ENZOLYTICS has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, partnership. View all ENZC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in ENZOLYTICS (ENZC) currently stands at 259 shares. Since September 2025, short interest has increased by 23.9%.
Days to Cover History
Days to cover for ENZOLYTICS (ENZC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
ENZC Company Profile & Sector Positioning
ENZOLYTICS (ENZC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ENZC often look at related companies in the same sector, including NEON BLOOM INC (NBCO), GREY MATTERS HEALTH INC (AGNPF), AXIM BIOTECHNOLOGIES INC (AXIM), VACCINEX INC (VCNX), and RESTART LIFE SCIENCES CP (NMLSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENZC's relative position within its industry.